The Effects of COVID-19 on the Placenta During Pregnancy
- PMID: 34603330
- PMCID: PMC8479199
- DOI: 10.3389/fimmu.2021.743022
The Effects of COVID-19 on the Placenta During Pregnancy
Erratum in
-
Corrigendum: The effects of COVID-19 on the placenta during pregnancy.Front Immunol. 2022 Sep 8;13:998406. doi: 10.3389/fimmu.2022.998406. eCollection 2022. Front Immunol. 2022. PMID: 36159853 Free PMC article.
Abstract
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. The virus primarily affects the lungs where it induces respiratory distress syndrome ranging from mild to acute, however, there is a growing body of evidence supporting its negative effects on other system organs that also carry the ACE2 receptor, such as the placenta. The majority of newborns delivered from SARS-CoV-2 positive mothers test negative following delivery, suggesting that there are protective mechanisms within the placenta. There appears to be a higher incidence of pregnancy-related complications in SARS-CoV-2 positive mothers, such as miscarriage, restricted fetal growth, or still-birth. In this review, we discuss the pathobiology of COVID-19 maternal infection and the potential adverse effects associated with viral infection, and the possibility of transplacental transmission.
Keywords: COVID-19; SARS-CoV-2; placenta; pregnancy; transplacental infection.
Copyright © 2021 Rad, Röhl, Stylianou, Allenby, Bazaz, Warkiani, Guimaraes, Clifton and Kulasinghe.
Conflict of interest statement
FSFG is a consultant and has a funded research agreement with Biotheus Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



References
-
- Senthil R, Kunchithapathan B, Ramalingam S, Manivannan P. COVID-19 Awareness and Its Impact in Rural and Urban Puducherry–a Community Based Cross Sectional Study. J Evol Med Dent Sci (2020) 9(51):3862–8. doi: 10.14260/jemds/2020/847 - DOI
-
- Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. . Update: Characteristics of Symptomatic Women of Reproductive Age With Laboratory-Confirmed SARS-Cov-2 Infection by Pregnancy Status—United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep 69(44):1641–7. doi: 10.15585/mmwr.mm6944e3 - DOI - PMC - PubMed
-
- Delahoy MJ, Whitaker M, O'Halloran A, Chai SJ, Kirley PD, Alden N, et al. . Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women With Laboratory-Confirmed COVID-19—COVID-NET, 13 States, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep (2020) 69(38)1347–54. doi: 10.15585/mmwr.mm6938e1 - DOI - PMC - PubMed
-
- Panagiotakopoulos L, Myers TR, Gee J, Lipkind HS, Kharbanda EO, Ryan DS, et al. . SARS-Cov-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics—Eight US Health Care Centers, March 1–May 30, 2020. MMWR Morb Mortal Wkly Rep 69. (2020) 69(38):1355–9. doi: 10.15585/mmwr.mm6938e2 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous